ATP7B and neoplasm: Research indicates that ATP7B can influence the resistance to copper-based anticancer agents, as some tumor cells may upregulate ATP7B to expel intracellular copper, thereby reducing the cytotoxicity of these drugs (Petruzzelli et al., 2022; Li P. et al., 2024).